Reaction Details Report a problem with these data
Target
SUMO-conjugating enzyme UBC9
Ligand
BDBM35371
Substrate
n/a
Meas. Tech.
AlphaScreen confirmatory assay for validation of inhibitors of SUMOylation
IC50
2160±n/a nM
Citation
 PubChem, PC AlphaScreen confirmatory assay for validation of inhibitors of SUMOylation PubChem Bioassay (2010)[AID] 
Target
Name:
SUMO-conjugating enzyme UBC9
Synonyms:
UBC9 | UBC9_HUMAN | UBCE9 | UBE2I | ubiquitin-conjugating enzyme E2I
Type:
Enzyme Catalytic Domain
Mol. Mass.:
18011.66
Organism:
Homo sapiens (Human)
Description:
gi_4507785
Residue:
158
Sequence:
MSGIALSRLAQERKAWRKDHPFGFVAVPTKNPDGTMNLMNWECAIPGKKGTPWEGGLFKLRMLFKDDYPSSPPKCKFEPPLFHPNVYPSGTVCLSILEEDKDWRPAITIKQILLGIQELLNEPNIQDPAQAEAYTIYCQNRVEYEKRVRAQAKKFAPS
  
Inhibitor
Name:
BDBM35371
Synonyms:
(7-chloro-5-pyrrolidino-benzofurazan-4-yl)amine | 7-chloranyl-5-pyrrolidin-1-yl-2,1,3-benzoxadiazol-4-amine | 7-chloro-5-(1-pyrrolidinyl)-2,1,3-benzoxadiazol-4-amine | 7-chloro-5-pyrrolidin-1-yl-2,1,3-benzoxadiazol-4-amine | MLS000042514 | SMR000048561 | cid_667215
Type:
Small organic molecule
Emp. Form.:
C10H11ClN4O
Mol. Mass.:
238.674
SMILES:
Nc1c(cc(Cl)c2nonc12)N1CCCC1
Structure:
Search PDB for entries with ligand similarity: